Latest filing published 19 Dec 2025 for Guggenheim Active Allocation Fund, €4,245.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ronald Nyberg has filed trades across 17 companies (mainly through SEC (Form 4)), most often in Advent Convertible & Income Fund, Guggenheim Enhanced Equity Income Fund (f/k/a Old Mutual/Claymore Long-Short Fund) and Advent/Claymore Enhanced Growth & Income Fund. Over a trading history stretching from 4 April 2006 to 18 December 2025, the count stands at 47 filings.
On the open market, the record shows 32 purchases worth €259k and 12 sales worth €88k. The net balance comes to €171k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2025 to date brings 3 purchases and no sales.
The median purchase comes to €6,517. On 2 out of 5 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -1.9%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 19 December 2025: an open-market purchase of €4,245, in Guggenheim Active Allocation Fund. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations